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Interleukin 6 is the major mediator ofthe early host response (the acute-phase
response) toinfection andinjury (reviewed in reference 1). Thedefense mechanisms
activated by IL-6 serve to contain tissue damage. The IL-6 gene can be expressed
in a wide range of cell types, including fibroblasts, endothelial cells, endometrial
stromal cells, keratinocytes, monocytes/macrophages, and also in avariety oftumor
cells.
Whereas it is clear that IL-6 has highly significant effects on the expression of
differentiated functions and on differentiation ofcells ofnonimmune and immune
systems (2-13), its effects on cell proliferation mainly involve either stimulation or
suppression oftheproliferation ofcertain kinds ofcells in which the genetic control
ofgrowth hasbeen altered. IL-6 promotes the growth ofcertain murine hybridomas
and plasmacytomas (14-16), and EBVinfected human B cells (17), but it inhibits
the proliferation ofa number ofbreast carcinoma cell lines and ofmyelomonocytic
Ml cells (11, 18, 19).
Epithelial cells areconnected toeach otherthrough acomplex system ofjunctions
(20-23). An importantquestion concernsthe mechanismwherebythejunctions are
modulated. Stoker and co-workers have reported thatfactors released fromcellsmay
either enhanceordecreasejunctional interactions betweencells (24-26). Afibroblast-
derived factor ofMr "50,000 affects a variety ofnormal epithelial cells by increasing
local motility, which resultsin scattering ofcontiguous cells (27, 28). This factor
has little effect on cell proliferation and it does not affect carcinoma cells (27, 28).
A 55,000 Mr factor produced by A2058 melanoma cells increases the motility of
melanoma cells (29).
During the course ofour studies ofthe inhibition ofcolony formation by recom-
binant and natural forms ofhuman IL-6 in two lines ofhuman breast carcinoma
cells(ZR75-1 andT-47D), we observed an IL-6-induced change incellmorphology
fromthe typicalpolygonal-cuboidal shape seenin epithelial cellsto astellate orfusi-
form shape. This change was commonly associated with separation of cells from
each other. We have defined the dynamics ofthese effects of IL-6, which persist for
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at least 10 d in the continued presence ofthe cytokine, but are reversed by its removal.
We show that IL-6 treatment causes increased local movement, as well as long-range
locomotion of ductal carcinoma cells, which is associated with the dissolution of
"adherens" (adhering) type cell junctions or structures.
Materials and Methods
Cell Lines and Culture Conditions.
￿
The T47D and ZR 75-1 lines of human ductal breast
carcinoma cells were obtained from the American Type Culture Collection, Rockville, MD.
The T-47 line was established from the pleural effusion obtained from a female patient with
an infiltrating ductal carcinoma ofthe breast (30). The differentiated epithelial subline T47D
(30) contains cytoplasmic junctions and receptors for 170-estradiol and other steroids (31,
32). T47D cells are responsive to but not dependent on estradiol for growth (33). The ZR75-1
line was established from the ascitic effusion of a female patient with an infiltrating ductal
carcinoma (34). The characteristic features ofthis cell line have remained constant irrespec-
tive of passage history and the cells closely resemble malignant cells in the original effusion
(34). As described by Engel et al. (34), ZR75-1 cells are often arranged in rosettes around
duct-like lumens and are connected by occasional desmosomes. The ZR75-1 cells possess
receptors for estrogen and other steroid hormones and are dependent on estradiol for growth
(33). Both the T47D and ZR75-1 lines were grown in RPMI 1640 medium containing 10%
FCS. For T47D cells the medium was supplemented with 0.2 U/ml insulin, and for ZR75-1
cells, with 10-s M 170-estradiol. Stock cultures of T47D and ZR75-1 cells were split 1 :5
once a week and refed once during the week.
IL-6 Preparations.
￿
The Escherichia coli-derived human IL-6 used represents a fusion pro-
tein that contains 181 amino acids of the IL-6 polypeptide fused to 34 amino acids from
0-galactosidase (6). Pelleted material from E. coli was dissolved in buffered 8 M urea and
partially purified using a MonoQ;FPLC column from which it was eluted with a stepwise
NaCl gradient (6). Most ofthe IL-6 eluted between 100 and 150 mM NaCl. This preparation
was -50% pure ("E. coli-derived"). IL-6 was further purified on a preparative 4 M urea-
acrylamide gel. IL-6 was eluted by crushing the appropriate gel band and leaving it overnight
in 8 M urea. This preparation was >90o7o pure ("E. coli-derived, gel-purified"). Two batches
ofE. coli-derived IL-6 were used: batch 100688 was used in all experiments except that shown
in Table I, in which batch 070288 was used.
The Chinese hamster ovary (CHO)' cell-derived preparation of recombinant human IL-6
(10, 35) was generouslyprovided by Dr. Steven C. Clark (Genetics Institute, Andover, MA).
The CHO-derived IL-6 was 90% pure and the specific activity, expressed in terms of stimu-
lation of IgG secretion by LESS lymphoblastoid cells, was 2 .5 x 106 U/mg.
Time-Lapse Cinemicrography.
￿
Cells were planted in 25-cm2 flasks (no. 2510025 ; Corning
Glass Works, Corning, NY) in 5.2 ml of growth medium at 1.3 x 103 cells/cm2 (T47D) or
5.2 x 103 cells/cm2 (ZR75-1). The following day the medium was replaced with growth
medium containing an appropriate control solution or IL-6 in the respective solution, each
diluted to the desired concentration with growth medium. The flasks were gassed with 5%
C02 in air and capped. Time-lapsecinemicrography of control and treated cultures was car-
ried out simultaneously usingtwo Zeiss inverted microscopes equipped with phase contrast
optics and Kodak cine cameras with EMDECO timing units. In most experiments a Ph 6.3 x
planar objective was used, the exposure time was 4 s, and the cultures were photographed
every 6 min for 10 d. For film analysis an L-W International projector was used that per-
mitted projection at speeds rangingfrom 1 to 24 frames per second as well as stop action viewing.
Serial Photomicrography.
￿
Grids of 1/4 x 1/4 inch squares were drawn on the bottoms of25-
cm2 flasks (no. 3012; Falcon Labware, Oxnard, CA). Cells were planted in 2.6 ml of growth
medium at 22 or 42 cells/cm2 (T47D) or 42 cells/cm2 (ZR 75-1). The day after planting the
medium was replaced with growth medium with or without IL-6 at the desired concentra-
i Abbreviations used in this paper . CHO, Chinese Hamster Ovary; IRS, immune rabbit serum; NRS,
normal rabbit serum.TAMM ET AL.
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tion. 1 or 2 d later eight colonies in each flask were identified by their location within the
grid. The number of cells per colony indicated that some had been initiated by small groups
of cells not completely dispersed by trypsinization. Presence of substantial numbers of cells
permitted more extensive evaluation of IL-6 effects on colony morphology. Daily serial pho-
tographs ofthe identifiedcolonies were takenfor up to 10 d using a M35 Zeiss inverted pho-
tomicroscope using a Ph-1 25 x phase contrast objective and TRI-X 400 ASA or TMY 400
ASA film.
Antibodiesand Immuno,fluorescence Microscopy.
￿
Mouse mAbs to vinculin were obtained from
Serotec (Oxford, England). AEl and AE3 mouse mAbs to cytokeratins were obtained from
Cappel Laboratories (San Diego, CA) and were used as a 1 :1 mixture. Rabbit polygonal
antibodies to desmoplakins I and II were a generous gift from Dr. W James Nelson (Institute
for Cancer Research, Philadelphia, PA). FITC-conjugated phalloidin was obtained from Mo-
lecular Probes (Eugene, OR). FITC-conjugated F(ab)2 fragments of goat antibodies to mouse
IgG or to rabbit IgG were obtained from Tago Inc. (Burlingame, CA).
For immunofluorescence localization of specific proteins, colonies of cellswere grown on
sterile glass coverslips in the presence ofIL-6-containingor control medium. Cells were fixed
with 496 formalin in neutral PBS and subsequently treated with 1% Triton-X100 in PBS.
Primary antibodies were reacted with fixed cells for 1-2 h and subsequently with FITC-
conjugatedsecond anibodies for 1 h. Fixedcells were directly reacted with FITC-conjugated
phalloidin (100 ng/ml) for 1 h. Photomicrographs were taken on a Zeiss microscope equipped
with epifluorescence optics. Original magnification of all photomicrographs is x 630.
Clonogenic Assay.
￿
200 T-47D cells or 400 ZR75-1 cells were seeded per well in six-well
plates in growth medium. The following day the medium was replaced with growth medium
containing an appropriate control solution or IL-6 in the respective solution, each diluted
to the desired concentration with growth medium. The plates were usually incubated for
14 d and then stained with the Giemsa stain. Colonies consisting of 10 or more cells were
counted in an inverted microscope. Colony morphology was evaluated as follows: a colony
was designated as epithelioid if over half of the cells in the colony had a polygonal shape,
and nonepithelioid if less than half were polygonal. The polygonal T47D cells were flatter
and had clearer borders than ZR75-1 cells. The nonpolygonal cells were angular in shape
and commonly possessed processes ofvariable length; such cells showed variable degrees of
separation from each other.
DNA Synthesis.
￿
ZR75-1 cells were seeded at a density of 5 x 104 cells/cm2 in growth
medium, 100 pl/well, in 96-well plates. 3 d laterthe medium was replaced with IL-6-containing
or control medium. After 20-24-h incubation, 10 pl of [3H]thymidine (6.7 Ci/mmol) was
added to a final concentration of 10 ACi/ml for 2 h at 37°C. Each well then received 30 pl
of 1 M citric acid for 10 min at room temperature. After two washes with cold PBS, 10%
TCA was added for 15 min at 4°C, and the cultures were then washed twice with 5% TCA.
Finally, the cells were lysed in 75 Al of 1% SDS, 1 mM EDTA, 0.1 N NaOH at 60°C for
1 h. The samples were then counted in a scintillation counter with Ready Safe liquid scintilla-
tion cocktail (Beckman Instruments, Fullerton, CA).
aiAntichymotrypsin Synthesis.
￿
Hep3B2 cells, obtained from the American Type Culture
Collection, were used to assay the ability of IL-6 preparations to stimulate a,-antichymo-
trypsin synthesis (6, 36). [31S]Methionine labeling of a,-antichymotrypsin was quantitated
by immunoprecipitation, SDS-PAGE, autoradiography, and laser densitometry, and is ex-
pressed in arbitrary absorbance units.
Results
Cell Morphology.
￿
We have investigated the effects of IL-6 on two cell lines derived
from metastic ductal breast carcinomas, T -47D, with a more differentiated morphology,
and ZR 75-1, with a less differentiated morphology. The three left panels in Fig.
1 illustrate the morphology ofcolonies ofthe T47D line of human breast carcinoma
cells. The great majority of the T47D cell colonies consist predominantly of contig-
uous flat polygonal cells with typical epithelial appearance, as illustrated by the top1652
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FIGURE 1 .
￿
Alteredshape of IL-6-treatedT-47D ductal breast carcinoma cells. T -47D cells were
planted at a density of 42 cells/cm2 andincubated for 11 d in the absence (left) or presence (right)
ofE . coli-derived gel-purified rIL-6 (150 ng/ml). (Left half)The upper two colonies are represen-
tative of the majority of the control T47D cell colonies composed of polygonal cells, and the
third illustrates the occurrence of cells of angular shape. (Right hatO Three colonies illustrate
the spectrum of IL-6-induced shape change from polygonal to angularand the partial or com-
plete separation ofcells from each other. Giemsa-stained colonies were photographed on 35-mm
film at a magnification of x 64 using a x25 objective . Final magnification, x 111 .
two colonies on the left . Some colonies are mixtures of polygonal cells and stellate
or fusiform cells with elongated processes (lowermost colony on the left). Angular
shape is associated with the separation of cells from neighbors . A small fraction of
theT-47D cell colonies are characterized by very dense packingof cells (not shown) .
IL-6 causes a change in cell shape from the polygonal to the stellate or fusiform
with an associated development ofspaces between cells . Thethree right-hand panels
in Fig . 1 illustrate different stages in this process . The cells that are still connected
to each other are seen as patches or as linear arrays of elongated cells. In addition,TAMM ET AL .
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some IL-6-treated colonies show increased variation in nuclear size and contour.
The time and concentration dependence of the IL-6-induced changes in cell shape
and colony organization are documented below.
Fig . 2 (three left panels) illustrates the morphology of the ZR75-1 line ofhuman
breast carcinoma cells. The colonies ofcontrol ZR75-1 cells aredenselypacked with
polygonal or cuboidal cells that often form what appear to be multi-layered, elon-
FIGURE, 2.
￿
Altered shape of IL-6-treatedZR75-1 ductal breast carcinoma cells . ZR75-1 cells
were planted at a density of42 cells/cm2and incubated for 14 d in the absence (left) or presence
(right) ofE . coli-derived partially purified HL-6 (150 ng/ml) . (Left hao Three colonies demon-
strate the typically very compact arrays of tightly packed controlZR75-1 cells with only occa-
sional cells or groups ofcells located at a distance from the body of the colony, but often linked
to the main part of the colony via intercellular bridges. (Righthat The upper two colonies are
representative of the common form found in IL-6-treated cultures ; the angular cells in these
colonies often have little cytoplasm andare separated from each other except for the cytoplasmic
processeswhich often connect the separated cells . Thelowermost colony on the right is represen-
tative of a minority of colonies in the IL-6-treated cultures ; their number is inversely related
to the concentration of IL-6 . Giemsa-stained colonies were photographed on 35-mm film at a
magnification of x64 using a x 25 objective . Final magnification, x 111 .1654
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gated, and convoluted aggregates. Parts ofsome colonies show evidence of separa-
tion fromeach other (centerleftpanel), and in some cases single cellsor small groups
of cells, are present in the immediate vicinity of a colony (upper left panel).
In IL-6-treated ZR75-1 cultures, the typical cells arehighly angular and possess
long processes that often connect noncontiguous cells or extend into areas without
cells (Fig. 2, two upper right panels). Occasionally a compact colony is seen (Fig.
2, lowermost panel on right); the frequency of such colonies is inversely related to
IL-6 concentration (see below).
Cell Motility by Time-Lapse Cinemicrography.
￿
Based on previous observations on
colony-forming epithelial cells exfoliated in human milk (25), we will refer to cells
that grow incontiguous cell sheets asjunction forming and to those that grow into
colonies ofnoncontiguous cells as deficient in junction formation.
Time-lapsecinemicrography ofcontrolT -47D cells(three experiments) showsthat
the majority ofcells arejunction forming, move little, and growinto colonies offlat
polygonal cells as illustrated in Fig. 1 (two upper panels on the left). However, even
within such colonies ofcontiguous cells forming epithelial sheets, individual cells
maytemporarily separate alongtheirborders from neighborsin aseries ofundulating
to- and fro- movementswhile remaining attached to the substrate and to other cells
at the poles. Such spindle-shaped or angular cells rarely leavetheirplacewithin the
colony and soonbecome laterally reattached to neighborsandreassume flatepithelioid
morphology.
A small fraction ofcells in control cultures ofT47Dcells consist ofcells deficient
injunction formation. Such cells move apart, and give rise to colonies ofscattered
stellate or fusiform cells amongwhich some cells may be laterally attached to each
otherasillustratedin Fig. 1 (leftlower panel). Onrare occasions ajunction deficient
control cell moves a considerable distance in the vicinity ofthe parent colony, but
long distance migration away from a colony was not seen.
IL-6 (E. coli-derived, 150 ng/ml; two time-lapse experiments) causes a marked
increase intheproportion ofT47Dcellsdeficientinjunction formation, whichscatter
ormaybe seen invariousstates ofpartial separation from neighbors, asis illustrated
in Fig. 1 on the right. After several days oftreatment many cells are spatially sepa-
rate. Some IL-6-treated T47D cells engage in locomotion over considerable dis-
tances. At low magnification these cells appear round in shape.
Time-lapse cinemicrography ofcontrol ZR75-1 cells (two experiments) revealed
somelocal cell movement even within the very compact multilayered colonies. IL-6
treatment (E. coli-derived; 150 ng/ml; two experiments) led to the contraction and
scattering of cells in most colonies.
To summarize, time lapse cinemicrography shows that IL-6 causes a marked in-
crease in local movement ofT47D and ZR75-1 cells with a small fraction of cells
showing locomotion over distances many times greater than the cell diameter.
Cell Shape andMotility by Serial Photomicrography.
￿
Higher resolution serial phase
contrast photomicrographs ofindividualcolonieswere takentoillustrate thechanges
seen by time-lapse cinemicrography. Fig. 3 shows photographs oftwo control colo-
nies of ZR75-1 cells (A and B), taken 3 and 5 d after medium change (i.e., 4 and
6 d after planting), which illustrate changes in the overall shape ofthe colonies and
the partial separation ofa few cells from the main bodyofthe colony (A). The split-
ting ofan entire colony into two parts was observed in another control colony (notTAMM ET AL .
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shown). However, overall the compact epithelial character ofcontrol colonies was
maintained over aprolongedperiod. Thecontrol cells showed fewsurfaceprojections.
Treatment with IL-6 (CHO cell-derived, 15 ng/ml), begun 1 d after planting,
caused a considerable change in cell shape and variable degrees of cell scattering
bythe third day (80 h) afterthe beginningoftreatment (Fig. 3, colonies C and D).
Photomicrographstakenon thefifthday(115 h) afteraddition ofIL-6 showprogres-
sive separation ofcells from each other. Many of the treated cells possess surface
projections, at least some ofwhich form connections between neighboringcells that
had moved apart.
A second experiment showed that 2 d oftreatment ofZR75-1 cells with IL-6 (15
ng/ml) had not yet caused majorchanges incolony morphology, whereas bythe third
day most colonies displayed changes in cell shape and cell scattering.
Reversal oftheEffects on Cell Shape, Motility, and Proliferation Upon Withdrawal ofIL-6.
Todetermine whether IL-6-induced changes were dependent on the continued ex-
posure to IL-6, we performed the following experiment. T-47D cells were planted
at low density and incubated in growth medium for 6 d to permit colonies to form.
The cultures were thenincubated for 7 d infresh control medium orin thepresence
ofIL-6 at 15 or 150 ng/ml, afterwhich the medium in all cultureswas replaced with
fresh growth medium andincubation continued. Eight colonies in each ofthe three
cultures were photographed serially, and the following representative samples are
presented: -1 d: photographs taken one day before the final medium change, i.e.,
after 6 d oftreatment; 3 d: taken 3 d after termination oftreatment; 5 d: taken 5 d
after termination of treatment.
In Fig. 4 control colony A is typical ofmost T47D cell colonies (compare also
with two top colonies on the left in Fig. 1). Control colony B illustrates cells that,
based on time-lapse cinemicrographic observations, are undergoinglocalmovements
associated withseparation andrejoiningofneighboring cells. As aresult, thecolony
has a looser structure.
TreatmentofT47D cell colonies for 6 d (cf., -1 d in Fig. 4) with IL-6 at 15 ng/ml
(C andD) or 150 ng/ml (E and F) causes dose-dependent changes in cell shape and
distribution. At 150 ng/ml, IL-6-induced separation of cells from each other be-
came evident in most colonies over a period of 2-3 d, as revealed in photographs
taken daily (not shown), and the cells assumed elongated and often curved shapes
with polarprocesses. Bythe sixthday ofexposuretoIL-6 at 150ng/ml, these changes
were marked (cf., Fig. 4, EandF). Similar changesdeveloped more slowly andwere
not as marked in cells exposed to IL-6 at 15 ng/ml (Fig. 4, C and D).
3 d after removal ofIL-6, there is clear evidence ofareversal ofthe IL-6-induced
changes as the cells are flatter and as neighboring cellshave become associated into
patches of cells (Fig. 4, 3 d, C-F). By the fifth day after removal of IL-6, reversal
ofthe IL-6-induced changes has progressed further (Fig. 4, 5 d, C-F). It should
be emphasized that in cultures ofT47D or ZR75-1 cells continuously treated with
IL-6 and observed by time-lapse cinemicrography for 10 d there was no evidence
of reversion of IL-6-induced changes in cell shape or inter-cellular association.
The increase in cell number with time is readily apparent in T-47D cell colonies
as the cells are flatterthan andnot as packed together as ZR75-1 cells. Fig. 5 shows
that T -47D cells proliferate with a doubling time ofN3 d andthat IL-6 inhibits the
proliferation ofT47D cellsin coloniesin aconcentration-dependent manner. WithinTAMM ET AL .
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FIGURE 5.
￿
Inhibition of T47D cell proliferation by
IL-6 andreversal of the inhibition upon withdrawal
of IL-6. Serial photographs taken in theexperiment
described in Fig. 4 were analyzed for increases in
cell number in five colonies pervariable, chosen be-
cause accurate cell counts could be performed. 1 d
afterthe first medium change, at which time the first
set ofphotographs was taken, the mean numbersof
cells per colony were as follows: control: 13; IL-6,
15 ng/ml: 11; IL-6, 150ng/ml: 12. Thecell numbers
on subsequent days were expressed as multiples of
theinitialcell counts andthegeometricmeansofsuch
multiples were calculated foreach groupoffive colo-
nies and plotted. In theinstanceswhereacolony no
longer fitted within thefieldofthe x25 objective, it
was rephotographed using a x16 or x 10 objective
forcell counting purposes.The arrowindicatestime
of second medium change, i.e., when IL-6 was re-
moved from the treated cultures.
24 h from the removal of IL-6, 15 ng/ml, the rate ofproliferation increased markedly
and for a period exceeded that of control cells. After removal of IL-6, 150 ng/ml,
thereis a 24-h delay, after which proliferation proceeds at a rate comparable to that
observed in control cells.
The compactness of control ZR 75-1 cell colonies precludes accurate counting of
cells within the colonies; however, as reported below, IL-6 inhibits [sH]thymidine
incorporation in subconfluent cultures ofZR75-1 cells. In a time-lapse cinemicro-
graphic experiment, in which ZR75-1 cells were incubated with CHO cell-derived
IL-6 (15 ng/ml) for 10 d and then for 5 d in the absence ofthe cytokine, the following
was observed: after removal of IL-6 a number of previously motile single cells be-
came stationary, flattened out, and proceeded to divide; with time, large colonies
of adhering cells formed.
Effects ofIL-6 on FocalAdhesionsandDesmosomes.
￿
Cellular adhesion to culture sur-
faces is mediated through focal adhesions (adhesion plaques) and close contacts in
many cell types. In epithelial cell types, focal adhesions and adherens-type intercel-
lular junctions are membrane insertion points for actin-containing filaments. An-
tivinculin mAbs were used to visualize focal adhesions in T-47D cells grown in con-
trol medium (Fig. 6, A and B). Prominent focal adhesions are visualized throughout
the central cell surface as well as at the peripheral edge ofboundary cells in a colony
(Fig. 6 B). In contrast, T47D cells grown in IL-6 (E. coli-derived, gel-purified, 150
ng/ml) for 8 d show either absence or marked reduction in the number of vinculin-
containing focal adhesions (Fig. 6, C and D). Whereas colonies ofT47D cells grown
in control medium show prominent Factin stress fibers, such microfilament bundles
are greatly diminished in T47D cellsgrown in the presence ofIL-6 (datanot shown).
Because fewerintercellular bridges were seen in many IL-6-treated cells, the effects
of IL-6 on intercellular desmosome formation were investigated by indirect im-
munofluorescence microscopy with antibodies directed against desmoplakins MI.
T47D cellsgrown in control medium showed frequent intercellular desmosomal at-
tachments as indicated by the punctate intercellular fluorescence in Fig. 7, A and
B. T47D cellsgrownin the presence of IL-6 (E. coli-derived, gel-purified, 150 ng/ml)TAMM ET AL.
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w mshow a marked reduction in the number of desmosomal attachments (Figure 7, C
and D). Colonies of IL-6-treated T -47D cells also show perinuclear retraction of
cytokeratin filaments and greatly diminished intercellularkeratin filament connec-
tions, corresponding to the decrease in desmosomal attachments (datanot shown).
DNA Synthesis.
￿
We have determined the dose-response relationship for the in-
hibitory effect of CHO cell-derived IL-6 on DNA synthesis in ZR75-1 cells and
relatedit tothat for its stimulatoryeffect on the synthesis ofan acute-phase protein,
at-antichymotrypsin, in the hepatoma line Hep3B2. Fig. 8 shows that inhibition
of DNA synthesis by IL-6 is detectable at 0.15 ng/ml and is maximal at 15 ng/ml.
Anti-IL-6 immune rabbit serum(1%) completely neutralized theinhibitionofDNA
synthesis when IL-6 was used at 15 ng/ml; when the concentration was increased
to 150 ng/ml, the neutralization waspartial (data not shown). Fig. 8 also shows that
the major IL-6-induced increase in at-antichymotrypsin synthesis occurs when the
concentration is raised from 1.5 to 15 ng/ml. In terms of the stimulatory activity
ofCHO cell-derivedIL-6 onIgG secretionbyLESS lymphoblastoid cells, therange
from 0.15 to 1.5 ng/ml corresponds to 0.36-36 U/ml (see Materials and Methods).
Thus, CHO IL-6 shows three widely different biological activities within a com-
parable concentration range in three different systems.
In two of the DNA synthesis experiments shown in Fig. 8 (" and ") we also
examined the relationship between concentration of CHO cell-derived IL-6 and
decreases in the number of ZR75-1 cell colonies and in the fraction ofpredomi-
nantly epithelioidcolonies. Decreases inboth parameterswere detected at 0.5 ng/ml
and they were maximal at 15 ng/ml (data not shown).
Table I illustrates the inhibitory effect ofE. coli-derived IL-6 on DNA synthesis
in T47D cellsandthecompleteblocking oftheinhibition byanti-IL-6 immune serum.
Comparison ofIL-6 Effects in T47D andZR-75-1 Cells with Respect to Colony Number
andMorphology.
￿
E. coli-derived IL-6 was used to quantitate the effects ofIL-6 on
T47D and ZR75-1 cell colony number and morphology in the same experiment.
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TABLE I
Inhibition of DNA Synthesis by E. coli-derived IL-6 in T-47 D Cells
and Neutralization of the Effect by Anti-IL-6 Immune Serum
[3H]Thymidine incorporation with the following sera:
IL-6
￿
None Normal Anti-IL-6'
' Immune rabbit serum was prepared using E. coli-derived human recombinant
IL-6 (6). It was used at a dilution of 1:100.
The latter was evaluated on the basis of the fraction of the colonies consisting of
predominantly epithelioid cells. Table II shows that ZR75-1 cellsaremore sensitive
to the effects of IL-6 than the better differentiated T -47D cells both in terms of the
inhibition of colony formation and the decrease in the fraction of predominantly
epithelioid colonies. Both effects of E. coli-derived IL-6 were completely blocked
by anti-IL-6 antiserum in both cell lines. Table II also shows that the CHOcell recom-
binant IL-6 preparation had a higher specific activity tL -in the E. coli recombinant
IL-6. This difference was also found in [3H]thymidine 7corporation experiments:
TABLE II
Effects of E. coli- and CHO Cell-derived IL-6 on Colony Formation
by T-47D and ZR-75 Cells
Controls for E. coli-derived rIL-6 were incubated in the presence of 0.8 or 8 mM urea in
growth medium, resulting in 68 and 76 colonies of T-47D cells per well, respectively, with
a mean of 72 and a plating efficiency of 36% . Of the control colonies 98 and 97%, respec-
tively, were epithelioid.
Controls for CHO cell-derived recombinant IL-6 were incubated in the presenceof0.2 MM
Tris/0.2 mM glycine in growth medium, which resulted in 56 colonies of T-47D cells per
well and a plating efficiency of 28% . Of the control colonies 100% were epithelioid.
Controls for E. coli-derived rIL-6 were incubated in the presence of 0.8 or 8 MM urea in
growth medium, resulting in 48 and 50 colonies of ZR-75-1 per well, respectively, with a
mean of 49 and a plating efficiency of 12% . Of the control colonies 98 and 99%, respective-
ly, were epithelioid.
Immune rabbit serum was prepared using E. coli-derived rIL-6 (6).
Cell line Reagents
Number
(percent
15 ng/ml
of colonies
o£ control)
150 ng/ml
Fraction of epithelioid
colonies (percent of control)
15 ng/ml 150 ng/ml
T-47D" E. coli IL-6 90 53 82 72
ZR-75-11 E. coli IL-6 65 30 89 31
T-47D E. coli IL-6
+ IRS, 1 :1006 112 101 98 101
ZR-75-1 E. coli IL-6
+ IRS, 1 :100 116 102 98 98
T-47D CHO cell IL-6 - 30 - 58
None 31,932 36,704
Percent of control
32,950
1 .5 72 69 103
15 54 57 105
150 36 37 106TAMM ET AL.
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asshown inFig. 8 (A), inZR75-1 cellsthepercent ofcontrol values forCHOcell-de-
rived IL-6 at 1.5, 15, and 150 ng/ml were 28, 16, and 14%, respectively; in the same
experiment the correspondingvalues forE. coliIL-6 were 50, 56, and 10%, and for
E. coli gel-purified IL-6 they were 67, 49, and 19%. E. coli IL-6 is prepared and
stored in 8 Murea, andthus maynot always fully renature when diluted into tissue
culture medium.
Discussion
We have demonstrated that ductal breast carcinoma cells treated with IL-6 un-
dergo striking morphological changes, separate from each other, and migrate apart.
The effects ofIL-6 on cell shape and cell-cell association are reversible upon with-
drawal ofthe cytokine from the medium. Although the morphological characteris-
tics ofuntreated colonies ofZR75-1 and T -47D cells are strikingly different, with
the flatter T47D cells often forming round colonies and the ZR-75-1 cells forming
tightly packed colonies suggestive ofduct walls, IL-6 causes similar effects in the
two lines. In IL-6-treated T47D cells, vinculin-containing focal adhesions as well
as intercellular desmosomal attachments are decreased.
IL-6 not only causes a marked change in colony morphology, which in T47D
colonieshas been independentlyobservedin anotherlaboratory (37), butitdecreases
both colony formation and cellproliferation. All ofthese effects canbe blocked with
anti-IL-6 antiserum. ZR75-1 cellsaremoresensitiveto IL-6effects thanT47Dcells.
There isasharp distinction between the effects ofIL-6 and those of IFN-0. IL-6
inhibits breast carcinoma cell proliferation, but increasescell motility, whereas IFN-S
inhibits both cell proliferation and motile functions in human fibroblasts (38, 39)
and cervical carcinoma cells (38, 40). Furthermore, treatment with IL-6 causes a
decrease in microfilament bundles, whereas IFN-0 increasesthe abundance ofthese
structures in fibroblasts (39) and of the submembrane microfilaments in cervical
carcinoma cells growing in suspension (41). IFN-f3 (500-2,400 U/ml) caused only
slight inhibition of['H]thymidine incorporation in T47D cells and at 500 U/ml had
no significant effect on [3H]thymidine incorporation in T47D cells and at 500 U/ml
had no significant effect on colony formation (42; unpublished results).
Epithelial celljunctions not only fulfill the requirements for an effective perme-
abilitybarrier and forcommunication between cells, but together with intracellular
cytoskeletal components theycontribute to the organization andarchitecture ofcells
in tissues. The"adherens" (adhering)-typejunctions(20)comprise twotypesofplaque
structure with different associated filamentsand playanimportantrolein the estab-
lishmentofanarchitecturalframework(22, 23). Onejunction-filament complexpro-
videsanchorage structures for actin-containing microfilaments and is characterized
byaplaque in theform ofalooselywovenmat that contains microfilaments, a-actinin,
and vinculin (21, 43). This type ofjunction can be belt-like, streak-like, or small-
plate-like. The othercomplex provides anchorage for intermediate filaments ofdi-
verse types and contains a rather rigid plaque, the desmosome, composed largely
of an exclusive set ofproteins, among which desmoplakin I and II are prominent
(22, 23, 44).
Our results show that IL-6 treatment of ductal breast carcinoma cells decreases
bothtypesofadherensjunctionsorstructures in thesecells, andthesechanges correlate
with altered morphology and increased motility of IL-6-treated cells.1664
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Time-lapse cinemicrography reveals that contiguous ductal carcinoma cellswithin
a colony in a culture that has not been treated with IL-6 can undergo separation
and rejoining and that this activity can be marked in different parts of a colony at
different times. The question arises whether IL-6 or a substance with IL-6-like ac-
tivity is made and released in relatively small amounts by groups ofcells in a colony,
and is responsible for the transient shape change and increased local movement of
groups of cells within a colony. Constitutive expression of the IL-6 gene has been
demonstrated in a number of tumor cell lines, including T24 renal carcinoma and
cardiac myxoma (2, 45). Strong IL-6 immunostaining has been observed in T -47D
cells in culture (46). Depending on variations in the rate of production by groups
of cells, there could be local concentration differences in IL-6 or another motility-
promoting cytokine, which would account for the heterogeneity in motile activity
of cellswithin a sheet. The transient nature of the increases in the motility of groups
of cells could reflect fall in local concentration of the cytokine due to diffusion or
other factors followed by reversal of the state of increased motility and reestablish-
ment ofjunctions between cells. In one preliminary time-lapse cinemicrographic
experiment we did not detect a major difference in the basal motile activity of ZR
75-1 cells incubated with anti-IL-6 immune serum. A small difference in basal ac-
tivity would be difficult to establish by this technique. As T47D cells lend them-
selves better to observations of morphologic and kinetic changes than ZR75-1 cells,
it will be of interest to explore the question further with T47D cells. Quantitation
of cell migration on a population basis using Boyden chambers (29, 47, 48) offers
an alternative approach.
The essential finding is that cells within an epithelial sheet are in a dynamic state
that can be influenced by cytokines. Epithelial cells engage in locomotion during
embryogenesis, normal differentiation in postembryonic tissues, wound healing, and
in some neoplastictissues. Locomotion and proliferation ofepithelial cellscan occur
separately, as exemplified during wound healing, when migration precedes the prolifer-
ative response of cells and migratory and proliferative cellular compartments are
spatially separate (reviewed in reference 49). Little is known about the existence or
function of motility-promoting cytokines in tissue morphogenesis or neoplasia. At
the cellular level, the stage-wise process of formation of desmosomes in response to
cell-to-cell contact, involving recruitment of desmoplakins I and II from a soluble
to an insoluble pool and redistribution to the plasma membrane in areas of cell-cell
contact has recently been described (50, 51). It remains to be determined whether
IL-6 inhibits the synthesis ofdesmoplakins and vinculin or their associative interac-
tions and distribution in cells. The recent reports that IL-6 decreases fibronectin
synthesis and increases collagenase production in different cells (52-54) raise the
possibility that IL-6 may also have significant effects on the extracellular matrix and
basement membrane integrity.
Overall, the dose-response relationships for the suppressive effects ofIL-6 on DNA
synthesis, colony number, and the proportion of epithelioid colonies, are similar.
Inhibition of [3H]thymidine incorporation by IL-6 is evident in subconfluent cul-
tures after only 20-24-h treatment (18; and present results), whereas changes in cell
and colony morphology become detectable after treatment for 2-3 d. The apparent
relationship between inhibition of growth and loss of the epithelioid character and
increased cell motility is of great interest and merits further study as it defines aTAMM ET AL.
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distinctive behavorial phenotype on the part oftransformed breast ductal epithelial
cells. TNFa causes 50% inhibition of[sH]thymidine incorporation in T -47D cells
at a concentration of 16 ng/ml, and its effect can be blocked by antiTNF immune
serum, but not by antibodies against IL-6 or IFN-0 (unpublished results). It will
be of interest to determine whether TNFci does or does not cause cell scattering,
andsimilarly, whethermethotrexate, aninhibitorofDNA synthesis, has any effects
on cell-cell association and motility.
Previousinvestigations in otherlaboratorieshave led to thetentative identification
of a 50,000 M, substance as the scatter factor for Madin-Darby canine kidney
(MDCK) andotherepithelial cells, which isproducedby embryonic fibroblasts(28),
and a 55,000 M, substance as an autocrine motility factor for melanoma cells (29).
These factors have properties characteristic ofproteins. Stoker's scatter factor lacks
activity in breast carcinoma cells and we have so far not detected scatter factor ac-
tivity with IL-6in MDCK cells(unpublished results). CHOcell-derivedIL-6 (15-150
ng/ml) alsohadno apparenteffect on cell-cell associationand morphology ofnormal
human keratinocytes, which, inthe presence ofIL-6, formed largecolonies indistin-
guishablefromcontrol colonies (unpublished results). IL-6 isthe first fullyidentified
and extensively characterized molecule capableofincreasing local motility ofbreast
cancer cells, and should proveuseful intheanalysisofthedetailed mechanismwhereby
motility of tumor cells can be increased by cytokines.
Cytological examinationoftissue aspirates has shown thatbenign cells arecharac-
terized byexcellentadhesiveness (except in lymph nodes, spleen, and bonemarrow)
and cancer cells by poor adhesiveness (55). Aggregates of ductal breast carcinoma
cells in aspirates are madeup ofloosely arranged cells, with partly or fully detached
cellsattheperipheryofthe clusters (55). As revealed bytime-lapse cinemicrography
ofbreast cancer cells in culture, cell-cell association representsadynamic state with
cells in a colony separating from each other and often, but not always, rejoining.
Alterations in intercellularjunctionshave been observedin a variety ofcancers, but
no conclusive evidence has been obtained linking such defects with invasion or
metastasis (56). Invasion may require changes in intercellular adhesion, but these
may be both focal and transient (57). A conventional microscopic examination of
junctionsin tumorsamples does notprovide information ondynamicaspects ofjunc-
tion formationordissolution in tumor cells, in particularthose neoplastic cells that
escape from the primary tumor. A variety ofapproaches, including intensive study
ofenzymesacting ontheextracellularmatrix proteins, will be importantinthe evalu-
ation ofcell-cellinteractions andcellmotility in studies ofinvasiveness andmetastasis.
Such approaches will clearly need to take account ofmotility-promoting cytokines
thatmay be produced by tumor cells themselves, by mesenchymal cells, orbyother
cells.
Summary
Treatment oftransformed breast duct epithelial cells withIL-6 produces a unique
cellular phenotype characterized by diminishedproliferation and increased motility.
Human ductal carcinoma cells (T-47D and ZR75-1 lines) are typically epithelioid
in shape and form compact colonies in culture. Time-lapse cinemicrography shows
that some untreated cells can transiently become fusiform or stellate in shape and
separate from each other within a colony, but they usually rejoin their neighbors.1666
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While IL-6 suppresses the proliferation of these carcinoma cells, the IL-6-treated
cells generally become stellate or fusiform and show increased motility. These changes
persist as long as the cells are exposed to IL-6. This results in the dispersal of cells
within colonies. The effects on cell growth, shape, and motility are reversible upon
removal ofIL-6. IL-6-treated T-47D cellsdisplay diminished adherens-type celljunc-
tions, as indicated by markedly decreased vinculin-containing adhesions and inter-
cellular desmosomal attachments. The effects on ZR75-1 cell shape, colony number,
and DNA synthesis are dependent on IL-6 concentration in the range from 0.15
to 15 ng/ml. Higher concentrations are required in T-47D cells for equivalenteffects.
Anti-IL-6 immune serum blocks IL-6 action. IL-6 represents a well-characterized
molecule that regulates both the proliferation and junction-forming ability ofbreast
ductal carcinoma cells.
We thank Dr. Steven C. Clark for generously providing CHO cell-derived human recom-
binant IL-6 and Ms. Celia K. Graham for expert preparation of manuscript copy.
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